A Comprehensive Review on Nanoparticles as Drug Delivery System and Their Role for Management of Hypertension

Area of Science:

• Cardiovascular Medicine
• Nanotechnology
• Pharmacology

Background:

• Hypertension is a major risk factor for severe cardiovascular diseases like stroke and heart failure.
• Conventional antihypertensive medications have limitations including poor bioavailability, frequent dosing, and side effects.
• Nanocarriers and nanoformulations show potential to enhance drug delivery and reduce toxicity.

Purpose of the Study:

• To review the challenges associated with traditional antihypertensive formulations.
• To highlight the potential of oral nanoparticulate systems in managing hypertension.
• To discuss the role of chronotherapeutics in hypertension treatment.

Main Methods:

• Literature review of existing studies on hypertension, drug delivery systems, and chronotherapeutics.
• Analysis of the benefits of nanocarriers for drug bioavailability and toxicity reduction.
• Exploration of the circadian patterns of blood pressure in relation to treatment strategies.

Main Results:

• Traditional antihypertensive formulations often suffer from suboptimal bioavailability and significant side effects.
• Nanoparticulate systems can improve drug bioavailability, reduce dosing frequency, and minimize toxicity.
• Chronotherapeutics are crucial for managing hypertension due to its circadian nature.

Conclusions:

• Oral nanoparticulate systems present a promising solution to overcome the limitations of conventional antihypertensive drugs.
• Integrating nanotechnology with chronotherapeutics can significantly improve hypertension management.
• Further research into nanoformulations is essential for developing more effective hypertension therapies.